Earnings Feed
Start Free
Home/Filings/4/0001179110-20-009649
4//SEC Filing

Schwartz Carl I. 4

Accession 0001179110-20-009649

CIK 0001446159other
View on SEC.govCompany Profile

Filed

Sep 8, 8:00 PM ET

Accepted

Sep 9, 8:55 PM ET

Size

21.2 KB

Accession

0001179110-20-009649

Insider Transaction Report

Form 4
Period: 2020-09-04
Predictive Oncology Inc.POAI
Schwartz Carl I.
10% Owner
Transactions
  • Disposition to Issuer

    Stock Options (Right to buy)

    2020-09-04−20,000→ 0 total
    Exercise: $7.48Exp: 2029-04-04→ Common Stock (20,000 underlying)
  • Award

    Stock Options (Right to buy)

    2020-09-04+20,000→ 20,000 total
    Exercise: $1.54Exp: 2029-04-04→ Common Stock (20,000 underlying)
  • Disposition to Issuer

    Stock Options (Right to buy)

    2020-09-04−4,219→ 0 total
    Exercise: $7.90Exp: 2029-07-01→ Common Stock (4,219 underlying)
  • Award

    Stock Options (Right to buy)

    2020-09-04+4,219→ 4,219 total
    Exercise: $1.54Exp: 2029-07-01→ Common Stock (4,219 underlying)
  • Disposition to Issuer

    Stock Options (Right to buy)

    2020-09-04−5,128→ 0 total
    Exercise: $6.50Exp: 2029-08-01→ Common Stock (5,128 underlying)
  • Award

    Stock Options (Right to buy)

    2020-09-04+5,128→ 5,128 total
    Exercise: $1.54Exp: 2029-08-01→ Common Stock (5,128 underlying)
  • Disposition to Issuer

    Stock Options (Right to buy)

    2020-09-04−6,050→ 0 total
    Exercise: $5.51Exp: 2029-09-01→ Common Stock (6,050 underlying)
  • Award

    Stock Options (Right to buy)

    2020-09-04+6,050→ 6,050 total
    Exercise: $1.54Exp: 2029-09-01→ Common Stock (6,050 underlying)
Holdings

  • Common Stock

    1,611,981
Footnotes (4)
  • [F1]All transactions reported on this form involve the repricing of stock options with an exercise price greater than $1.54 to an exercise price of $1.54, as approved by shareholders at the 2020 annual meeting, with certification of the shareholder vote as of September 4, 2020.
  • [F2]Currently exercisable.
  • [F3]Held by the Carl I. Schwartz Revocable Living Trust
  • [F4]15,000 shares are currently vested; 2,500 shares vest on each of 10/4/2020 and 1/4/2021.

Documents

1 file

Issuer

Predictive Oncology Inc.

CIK 0001446159

→
Entity typeother

Related Parties

1
  • filerCIK 0001573354

Filing Metadata

Form type
4
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 8:55 PM ET
Size
21.2 KB
View on SEC.gov